STAT+: PhRMA sues over Trump policy mandating lower drug prices in Medicare
Headline from STAT
The brand drug industry’s main trade group is suing the Trump administration over a pilot program tying Medicare drug prices to those in peer countries.
STAT's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
The brand drug industry’s main trade group is suing the Trump administration over a pilot program tying Medicare drug prices to those in peer countries.
The pharmaceutical industry’s top lobby group on Wednesday sued to invalidate the Trump administration’s efforts to benchmark U.S. drug prices to lower costs overseas in the Medicare health insurance program, arguing that it is an illegal government overreach.
The pharmaceutical industry's top lobby group sued Wednesday to invalidate the Trump administration's efforts to benchmark U.S. drug prices to lower costs overseas in the Medicare health insurance program, arguing that it is an illegal government overreach.
